Blood Test to Detect Cancer Molecules Years After Lung Cancer Treatment

A recent study conducted by Yale researchers has identified a blood test capable of detecting cancer-derived molecules in patients with lung cancer years after their treatment. The findings suggest the potential utility of this tool in monitoring patients post-treatment and informing future therapy decisions.

The research focuses on the presence of specific molecules in the bloodstream that originate from cancer cells. By analyzing these markers, scientists aim to provide insights into whether traces of cancer remain or if new therapeutic interventions may be necessary. The study highlights the role such tests could play in advancing personalized medicine, offering a tailored approach to long-term care for individuals who have undergone lung cancer treatment.

Date: 18 March, 2025

Newsflash | Powered by GeneOnline AI

Author

Mark Chiang